The European Medicines Agency (EMA) announced the recommended immediate suspension and recall of AbbVie and Biogen’s multiple sclerosis (MS) drug...
Read moreShire plc announced new Phase 3 results from the HELP Study™, a global, multi-center, randomized, double-blind placebo-controlled parallel group trial...
Read moreTeva Pharmaceutical Industries Ltd., announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for fremanezumab,...
Read moreSanofi Recognized by Top Employers Institute for Good Practice in Employee Development.Sanofi has been officially certified today as a 2018...
Read moreBeiGene, Ltd. and Boehringer Ingelheim Biopharmaceuticals (China) Ltd. announced that the two companies have entered into a commercial supply agreement...
Read moreReCor Medical announced randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's...
Read moreAptar Pharma, a leading drug delivery systems provider, will once again bea key exhibitor at Pharmapack 2018, Europe's dedicated pharmaceutical...
Read moreGSK welcomes the launch of the UK Government’s Life Sciences Sector Deal, which builds on the Industrial Strategy published by...
Read moreCanon BioMedical is pleased to announce our latest geographic expansion into the German-speaking countries of Austria, Germany, and Switzerland. We...
Read moreSanofi's Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.